Elevation Other Non Cash Items from 2010 to 2024

ELEV Stock  USD 0.56  0.02  3.52%   
Elevation Oncology Other Non Cash Items yearly trend continues to be fairly stable with very little volatility. Other Non Cash Items will likely drop to about -168 K in 2024. During the period from 2010 to 2024, Elevation Oncology Other Non Cash Items regression line of quarterly data had r-squared of  0.000056 and coefficient of variation of (250.24). View All Fundamentals
 
Other Non Cash Items  
First Reported
2010-12-31
Previous Quarter
-160 K
Current Value
-168 K
Quarterly Volatility
1.4 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Elevation Oncology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Elevation Oncology's main balance sheet or income statement drivers, such as Depreciation And Amortization of 37 K, Interest Expense of 4.4 M or Selling General Administrative of 9.2 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.35. Elevation financial statements analysis is a perfect complement when working with Elevation Oncology Valuation or Volatility modules.
  
Check out the analysis of Elevation Oncology Correlation against competitors.
For more information on how to buy Elevation Stock please use our How to Invest in Elevation Oncology guide.

Latest Elevation Oncology's Other Non Cash Items Growth Pattern

Below is the plot of the Other Non Cash Items of Elevation Oncology over the last few years. It is Elevation Oncology's Other Non Cash Items historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Elevation Oncology's overall financial position and show how it may be relating to other accounts over time.
Other Non Cash Items10 Years Trend
Very volatile
   Other Non Cash Items   
       Timeline  

Elevation Other Non Cash Items Regression Statistics

Arithmetic Mean(550,933)
Coefficient Of Variation(250.24)
Mean Deviation611,476
Median(451,000)
Standard Deviation1,378,636
Sample Variance1.9T
Range6.8M
R-Value0.01
Mean Square Error2T
R-Squared0.000056
Significance0.98
Slope2,307
Total Sum of Squares26.6T

Elevation Other Non Cash Items History

2024-168 K
2023-160 K
202274 K
20211.6 M
2020-5.1 M

About Elevation Oncology Financial Statements

Elevation Oncology investors use historical fundamental indicators, such as Elevation Oncology's Other Non Cash Items, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Elevation Oncology. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Non Cash Items-160 K-168 K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Elevation Stock Analysis

When running Elevation Oncology's price analysis, check to measure Elevation Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elevation Oncology is operating at the current time. Most of Elevation Oncology's value examination focuses on studying past and present price action to predict the probability of Elevation Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elevation Oncology's price. Additionally, you may evaluate how the addition of Elevation Oncology to your portfolios can decrease your overall portfolio volatility.